Literature DB >> 16394353

Dexamethasone-cyclophosphamide pulse therapy in systemic lupus erythematosus.

Ravindra Dhabhai1, G Kalla, M K Singhi, B C Ghiya, Dilip Kachhawa.   

Abstract

BACKGROUND AND AIMS: Therapy systemic lupus erythematosus (SLE) has been generally discouraging. Methyl-prednisolone pulse therapy has been used for various connective tissue disorders. We used intravenous dexamethasone cyclophosphamide pulse therapy to treat SLE.
METHODS: Fourteen patients (10 females and 4 males) between the age of 15-48 years with definite or classical clinical criteria laid by American Rheumatism Association criteria were treated by Dexamethasone-Cyclophosphamide pulse (DCP) therapy at our center.
RESULTS: It was possible to induce a complete clinical remission with DCP therapy in most of the patients thereby offering them life free from disease and drugs. The side effects commonly observed with conventional daily dose regimen of corticosteroids were not present or were mild.
CONCLUSIONS: Almost all patients had good response after 3-4 pulses to allow them a normal life style. Fever, malar rash and oral ulceration responded early but photosensitivity, discoid rash, alopecia and joint pains took some more time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16394353     DOI: 10.4103/0378-6323.13778

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  1 in total

1.  Dexamethasone- cyclophosphamide pulse in collagen vascular diseases: An observation.

Authors:  Sudip Das; Parag Prasun Giri; Aloke Kr Roy
Journal:  Indian Dermatol Online J       Date:  2011-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.